Leader of the firm’s life sciences transactions practice and a co-leader of the firm’s global life sciences industry team, Alan B. Leeds represents life sciences companies from early-stage biotechnology startups to global pharmaceutical companies, as well as specialty pharma, medical device, and other technology companies. He also works with venture capital firms that focus on the life sciences industry. Alan’s practice includes negotiating and structuring strategic alliances and other complex collaborations, corporate partnering arrangements, licensing transactions, acquisitions and divestitures, manufacturing and supply agreements, distribution arrangements, co-promotion arrangements, and joint ventures.
Alan assists clients with the full spectrum of commercial activities, from early-stage research collaborations to global strategic alliances for the development and commercialization of products. In addition, he advises on financing transactions such as equity investments and royalty monetization with a focus on the life sciences industry.
Alan is the author or co-author of a number of articles relating to the life sciences industry, including, in the New Jersey Law Journal, “Keep One Eye on the Collaboration, And the Other on Exit Events,” and “Dividing the Intellectual Property Pie in the Life Sciences Industry.” Alan is also a contributor to Morgan Lewis’s Emerging Life Sciences Companies Deskbook. He has spoken on subjects related to the life sciences industry at various life sciences–related conferences, including Licensing Executives Society (LES) annual meetings.
Recognized, IAM Patent 1000: The World’s Leading Patent Professionals (2020–2022)
Recognized, IP Transactions Star – New Jersey, Managing Intellectual Property (2021, 2022)
Ranked, Corporate/M&A, New Jersey, Chambers USA (2018–2022)
Recommended, Industry focus: Healthcare: life sciences, The Legal 500 US (2021, 2022)
Recommended, Intellectual property: Patents: licensing, The Legal 500 US (2021, 2022)
Next Generation Lawyer, Industry focus: Healthcare: life sciences, The Legal 500 US (2018–2020)
Recommended, Industry focus - Healthcare - life sciences, The Legal 500 US (2017)
Life Sciences Star, Financial and Corporate, LMG Life Sciences (2015–2022)
Member, Practice Group of the Year, Intellectual Property, Law360 (2019)
Recognized, BTI Client Service All-Star (2015, 2020)